News
-
In 2022, EMA recommended 89 medicines for marketing authorisation
In 2022, EMA recommended 89 medicines for marketing authorisation. Of these, 41 had a new active ingredient…
Leggi » -
R&D spending doesn't justify high drug prices. An analysis on the BMJ
The "British medical journal" published an interesting analysis entitled "High drug prices are not ...
Leggi » -
Too many VAT numbers in Italy compared to European Partners
Italy is the country of the VAT numbers Blue Suitcase – 15 February 2023 by Mattia Marasti The labor market in…
Leggi » -
FRANCE. Roche and Novartis acquitted, they will not have to pay 444 million euros
The maxi-fines dating back to last 2020 and imposed in France on the two pharmaceutical giants for abuse of position have been canceled…
Leggi » -
AIFA updates the Transparency Lists
AIFA press release. February 15, 2023 In order to allow the Regions and autonomous Provinces to uniformly apply what…
Leggi » -
Ethics Committees. Clinical trials of medicines and medical devices, the decrees on ethics committees in the Journal
"With the signing of the four decrees on Ethics Committees, a decisive step has been taken, which has been awaited for years, towards…
Leggi » -
IV FILCTEM CGIL National Congress in Turin from 15 to 17 February
The IV National Congress of FILCTEM CGIL, the trade union of the chemical sectors, opened today in Turin,…
Leggi » -
SNAMI declares a state of agitation to protect increasingly harassed doctors!
SNAMI dichiara lo stato di agitazione a tutela dei medici sempre più vessati ! Roma, 13 febbraio 2023 – Il…
Leggi » -
Deloitte reports. In 2022, the rate of return on investment has decreased. The top 20 companies spent 139 billion on R&D
"Measuring the return from pharmaceutical innovation 2022", the thirteenth annual report of the Deloitte Center for Health, has been published. The…
Leggi » -
Self-medication drugs. In 2022 turnover at 2.9 billion (+19%)
Sono 287 mln le confezioni vendute (+15,9%) (Il Sole 24 Ore Radiocor Plus) – Roma, 13 feb – Con una…
Leggi »